Clinical Trial Update: A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing EVL/GVS alone vs EVL/GVS with propranolol for liver cirrhosis and hepatocellular carcinoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Liver Cirrhosis, Hepatoma | Phase 4 | Status: UNKNOWN